The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of initial vs delayed docetaxel therapy in veterans with metastatic hormone sensitive prostate cancer and high volume of disease.
 
Jasnoor Malhotra
No Relationships to Disclose
 
Robert Wilson
No Relationships to Disclose
 
Andrew Schlager
No Relationships to Disclose
 
Vaidehi Panchal
No Relationships to Disclose
 
Harshraj Leuva
Consulting or Advisory Role - Seattle Genetics/Astellas
 
Mengxi Zhou
No Relationships to Disclose
 
Antonio Fojo
Honoraria - Daiichi Sankyo
Consulting or Advisory Role - Acrivon Therapeutics (I); Acrivon Therapeutics (I); Astellas Pharma; ElmediX (I); PEGASCY (I)
Research Funding - Ipsen (Inst); Pfizer (Inst); RenovoRx (I); Sun Biopharma (Inst)
Patents, Royalties, Other Intellectual Property - "METHODS FOR TREATING PANCREATIC CANCER WITH A COMBINATION OF ROMIDEPSIN AND DES-METHYL PATEAMINE A" (I)
 
Martin Schoen
Consulting or Advisory Role - ConcertAI
Research Funding - Astellas Pharma (Inst)